These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7825948)

  • 1. [New lipid factors of cardiovascular risk].
    Bruckert E; Turpin G
    Ann Cardiol Angeiol (Paris); 1994 Oct; 43(8):458-60. PubMed ID: 7825948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulse wave velocity in familial combined hyperlipidemia.
    ter Avest E; Holewijn S; Bredie SJ; van Tits LJ; Stalenhoef AF; de Graaf J
    Am J Hypertens; 2007 Mar; 20(3):263-9. PubMed ID: 17324737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia.
    Skoumas I; Masoura C; Pitsavos C; Tousoulis D; Papadimitriou L; Aznaouridis K; Chrysohoou C; Giotsas N; Toutouza M; Tentolouris C; Antoniades C; Stefanadis C
    Int J Cardiol; 2007 Oct; 121(2):178-83. PubMed ID: 17188767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diet, smoking, and blood lipids in patients with combined familial hyperlipidaemia.
    Králíková E; Ceska R; Rames J
    Cent Eur J Public Health; 1999 Feb; 7(1):19-23. PubMed ID: 10084016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of risk factors, plasma lipids, lipoproteins and dyslipidemias in a small Mediterranean island: the Ustica Project.
    Barbagallo CM; Polizzi F; Severino M; Onorato F; Noto D; Cefalù AB; Rizzo M; Notarbartolo A; Averna MR
    Nutr Metab Cardiovasc Dis; 2002 Oct; 12(5):267-74. PubMed ID: 12616806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small, dense low density lipoprotein (LDL) and the insulin resistance syndrome (IRS).
    Festa A
    Clin Lab; 2001; 47(3-4):111-8. PubMed ID: 11294573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipoprotein (a), a cardiovascular risk factor: importance of its determination in current clinical practice].
    Couderc R; Maachi M
    J Mal Vasc; 1998 Jun; 23(3):165-75. PubMed ID: 9669219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum lipid profiles and risk of cardiovascular disease in three different male populations in northern Nigeria.
    Glew RH; Kassam HA; Bhanji RA; Okorodudu A; VanderJagt DJ
    J Health Popul Nutr; 2002 Jun; 20(2):166-74. PubMed ID: 12186197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of insulin resistance in familial combined hyperlipidemia.
    Veerkamp MJ; de Graaf J; Stalenhoef AF
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1026-31. PubMed ID: 15731490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid and insulin levels in obese children: changes with age and puberty.
    Pinhas-Hamiel O; Lerner-Geva L; Copperman NM; Jacobson MS
    Obesity (Silver Spring); 2007 Nov; 15(11):2825-31. PubMed ID: 18070774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between familial combined hyperlipidemia and insulin resistance.
    Jackuliaková D; Vaverková H; Karásek D
    Vnitr Lek; 2008 Nov; 54(11):1045-53. PubMed ID: 19069677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid disorders in type 2 diabetes.
    Braun LT
    Nurs Clin North Am; 2001 Jun; 36(2):291-302, vii. PubMed ID: 11382564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of lipoprotein (a) are related to family risk factors of cardiovascular disease in children and adolescents from Maracaibo, Venezuela.
    Souki-Rincón A; Urdaneta J; Mengual E; Torres D; Cano-Peñaloza R; García-Camacho D; Bermúdez-Pírela V; Sorell L; Cano-Ponce C; Almarza J; Israili Z; Hernández-Hernandez R; Velasco M
    Am J Ther; 2008; 15(4):403-8. PubMed ID: 18645346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Physical activity and the metabolic syndrome].
    Westheim A; Os I; Hjermann I
    Tidsskr Nor Laegeforen; 1993 Feb; 113(6):723-4. PubMed ID: 8465338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathophysiologic aspects of hyperlipoproteinemias].
    Soska V
    Vnitr Lek; 2000 Sep; 46(9):506-9. PubMed ID: 11344641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS).
    Williams K; Sniderman AD; Sattar N; D'Agostino R; Wagenknecht LE; Haffner SM
    Circulation; 2003 Nov; 108(19):2312-6. PubMed ID: 14581403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up in a lipid clinic improves the management of risk factors in cardiovascular disease patients.
    Gavish D; Leibovitz E; Elly I; Shargorodsky M; Zimlichman R
    Isr Med Assoc J; 2002 Sep; 4(9):694-7. PubMed ID: 12440233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.